Bo Tang

ORCID: 0000-0003-4820-5649
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Research and Treatments
  • Nanoplatforms for cancer theranostics
  • Virus-based gene therapy research
  • Cancer, Hypoxia, and Metabolism
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Parallel Computing and Optimization Techniques
  • Immune cells in cancer
  • Genomics and Phylogenetic Studies
  • Congenital Diaphragmatic Hernia Studies
  • Cytokine Signaling Pathways and Interactions
  • Parasites and Host Interactions
  • Adenosine and Purinergic Signaling
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Chemokine receptors and signaling
  • Drug Transport and Resistance Mechanisms
  • Reproductive Biology and Fertility
  • Reproductive Health and Technologies
  • Phytase and its Applications
  • Renal and related cancers
  • Parasitic Infections and Diagnostics
  • Molecular Biology Techniques and Applications
  • Hepatitis Viruses Studies and Epidemiology
  • Chronic Kidney Disease and Diabetes

Powerchina Huadong Engineering Corporation (China)
2024

PowerChina (China)
2024

Nanjing University
2009-2021

First Affiliated Hospital of Nanchang University
2021

Nanchang University
2021

Kunming Medical University
2020

Taian City Central Hospital
2016

Army Medical University
2012

Southwest Hospital
2012

Pharmaceutical Biotechnology (Czechia)
2009-2011

The weakened tumour colonization of attenuated Salmonella has severely hampered its clinical development.In this study, we investigated whether an anti-inflammation and antiangiogenesis compound triptolide could improve the efficacy VNP20009, a highly strain, against mice melanoma.By comparing effects conventional VNP20009 monotherapy combination therapy that uses both found significantly improved by reducing number infiltrated neutrophils in melanoma, which led to larger necrotic area...

10.7150/thno.18816 article EN cc-by Theranostics 2017-01-01

mediated cancer therapy has achieved remarkable anti-tumor effects in experimental animal models, but the detailed mechanism remains unsolved. In this report, active involvement of host immune response process was confirmed by comparing tumor-suppressive Salmonella immunocompetent and immunodeficient mice bearing melanoma allografts. Since flagella are key inducers during bacterial infection, were genetically disrupted to analyse their Salmonella-mediated therapy. The results showed that...

10.1016/j.apsb.2021.04.019 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2021-05-07

Tumor-associated macrophages (TAMs) in the tumor microenvironment contribute to poor prognosis gastric cancer (GC). However, underlying mechanism by which TAMs promote GC progression and metastasis remains elusive. Expression of POU1F1 was detected 60 matched GC-normal tissue pairs using qRT-PCR immunohistochemistry (IHC) analysis. The correlation between clinical-pathological factors patients were further assessed. Cell proliferation monitored CCK-8, colony formation,...

10.1038/s41419-021-03703-x article EN cc-by Cell Death and Disease 2021-04-29

Attenuated Salmonella typhimurium ( S. ) strains can selectively grow and express exogenous genes in tumors for targeted therapy. We engineered strain VNP20009 to secrete tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) under the control of a hypoxia‐induced nirB promoter examined efficacy Salmonella‐ mediated expression TRAIL mice bearing melanoma TRAIL‐resistant RM‐1 tumor. found that VNP preferentially accumulated tissues effectively drove TRAIL. Compared with recombinant...

10.1111/j.1349-7006.2011.02147.x article EN Cancer Science 2011-11-07

Tumor-targeting bacteria have been developed as powerful anticancer agents. Salmonella typhimurium VNP20009, a representative tumor-targeting strain, has systemically administered single-agent therapy at doses of 1 x 10(6) to 3 colony-forming unit (cfu)/mouse, or in combination with other antitumor agents 10(4) 2 10(5) cfu/mouse. Recently, we reported that oral delivery VNP20009 the dose 10(9) cfu/mouse induced significant effects comparable by systemic administration this strain To further...

10.1111/j.1349-7006.2009.01337.x article EN other-oa Cancer Science 2009-09-01

Solid tumors often contain hypoxic and necrotic areas that can be targeted by attenuated Salmonella typhimurium VNP20009 (VNP). We sought to develop a hypoxia- inducible promoter system based on the tumor-specific delivered strain VNP confine expression of therapeutic gene specifically or selectively within tumor microenvironment. A hypoxia-inducible - adhE was screened from hypoxia-regulated endogenous proteins through two-dimensional gel electrophoresis matrix-assisted laser desorption...

10.1074/mcp.m111.009399 article EN cc-by Molecular & Cellular Proteomics 2011-04-08

Background Schistosomiasis japonica is a zoonotic parasitic disease and oral vaccine delivery system would be benefit for prevention of this disease. Although attenuated salmonella has been used as an antigen expression vector development, the membrane-bound vacuoles in which bacteria reside hinders presentation expressed heterologous antigens to major histocompatibility complex (MHC) molecules. The present work Salmonella typhimurium strain VNP20009 secretory Sj23LHDGST bivalent from...

10.1371/journal.pntd.0001313 article EN cc-by PLoS neglected tropical diseases 2011-09-06

Attenuated Salmonella typhimurium (S. typhi­murium) strain VNP20009 has been employed as a powerful anticancer agent due to its selective accumulation in tumors for targeted therapy. S. demonstrated constitute delivery tool carrying antiangiogenic or proapoptotic genes that treat cancer. The hydrodynamic tail vein (HTV) injection of naked plasmid DNA developed an effective gene strategy, which successfully used vivo. aim this study was develop combination therapy and HTV interleukin-21...

10.3892/mco.2013.90 article EN Molecular and Clinical Oncology 2013-03-11

Immunotherapy with tumor lysate-pulsed dendritic cells (DCs) is one of the breakthrough strategies used in treatment cancer. However, DC-based immunotherapies for osteosarcoma are limited. In present study, preclinical studies a C3H mouse model (produced by subcutaneous injection LM8 murine cells) validated concept that cell bone marrow-derived DCs may evoke more potent immune response compared have been matured using polyinosinic:polycytidylic acid (poly I:C). A cytotoxic T lymphocyte (CTL)...

10.3892/ol.2016.4714 article EN Oncology Letters 2016-06-15

e13655 Background: The reactivation of telomerase reverse transcriptase ( TERT) is one the characters that make cancer cells immortal. TERT expression has been shown in various human cancers.However, landscape alterations Chinese patients with solid tumors still remains unclear. Here, we illustrated profile variations tumor by using next generation sequencing (NGS)-based targeted sequencing. Methods: Formalin fixed, paraffin embedded (FFPE) tissues and matching blood samples were collected...

10.1200/jco.2020.38.15_suppl.e13655 article EN Journal of Clinical Oncology 2020-05-20
Coming Soon ...